Inhibikase Therapeutics, Inc. (IKT)
1.80
+0.04
(+2.27%)
USD |
NASDAQ |
Feb 23, 16:00
1.80
0.00 (0.00%)
After-Hours: 18:41
Inhibikase Therapeutics Price : 1.80 for Feb. 23, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Beta Bionics, Inc. | 13.78 |
| ACADIA Pharmaceuticals, Inc. | 24.75 |
| Agenus, Inc. | 3.06 |
| Alnylam Pharmaceuticals, Inc. | 329.59 |
| Savara, Inc. | 5.72 |
Price Related Metrics
| Price to Book Value | 2.994 |
| Earnings Yield | -31.69% |
| Market Cap | 218.28M |